---
title: "Bailong Chuangyuan: The net profit for the third quarter was 94.8441 million yuan, a year-on-year increase of 50.48%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263272556.md"
description: "Bailong Chuangyuan announced that the revenue for the third quarter was 320 million yuan, a year-on-year increase of 10.61%; the net profit was 94.8441 million yuan, a year-on-year increase of 50.48%. The revenue for the first three quarters was 969 million yuan, a year-on-year increase of 18.10%; the net profit was 265 million yuan, a year-on-year increase of 44.93%"
datetime: "2025-10-29T11:14:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263272556.md)
  - [en](https://longbridge.com/en/news/263272556.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263272556.md)
generator: "portal-rs"
---

# Bailong Chuangyuan: The net profit for the third quarter was 94.8441 million yuan, a year-on-year increase of 50.48%

Bailong Chuangyuan announced that its revenue for the third quarter was 320 million yuan, a year-on-year increase of 10.61%; net profit was 94.8441 million yuan, a year-on-year increase of 50.48%. Revenue for the first three quarters was 969 million yuan, a year-on-year increase of 18.10%; net profit was 265 million yuan, a year-on-year increase of 44.93%

### Related Stocks

- [605016.CN](https://longbridge.com/en/quote/605016.CN.md)

## Related News & Research

- [Pure One Corporation Records 25.4% Gas Readings from Drilling at Surat Basin Venus-2H Well](https://longbridge.com/en/news/296561138.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [13:22 ET/C O R R E C T I O N -- Rayence/](https://longbridge.com/en/news/296256530.md)
- [07:35 ETREDICO and One Orchard launch InfraMed Properties -- a medical outpatient investment platform poised for nationwide growth](https://longbridge.com/en/news/296483902.md)
- [Sedana Medical says FDA accepts NDA for isoflurane ICU sedation system for review](https://longbridge.com/en/news/296306389.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**